OXYCONTIN Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Which patents cover Oxycontin, and when can generic versions of Oxycontin launch?
Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are twenty-one patents protecting this drug and five Paragraph IV challenges.
This drug has five hundred and sixty-two patent family members in forty-nine countries.
The generic ingredient in OXYCONTIN is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxycontin
A generic version of OXYCONTIN was approved as oxycodone hydrochloride by SPECGX LLC on June 30th, 2004.
Summary for OXYCONTIN
International Patents: | 562 |
US Patents: | 21 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 23 |
Clinical Trials: | 60 |
Patent Applications: | 3,037 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for OXYCONTIN |
Drug Sales Revenues: | Drug sales revenues for OXYCONTIN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for OXYCONTIN |
What excipients (inactive ingredients) are in OXYCONTIN? | OXYCONTIN excipients list |
DailyMed Link: | OXYCONTIN at DailyMed |



Recent Clinical Trials for OXYCONTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
3D Medicines | Phase 2 |
Medical College of Wisconsin | Phase 2 |
Khashayar Vaziri | Phase 2 |
Pharmacology for OXYCONTIN
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for OXYCONTIN
Paragraph IV (Patent) Challenges for OXYCONTIN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 20 mg | 022272 | 2 | 2010-10-29 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 15 mg | 022272 | 1 | 2010-10-28 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 10 mg | 022272 | 1 | 2010-10-25 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 30 mg, 60 mg and 80 mg | 022272 | 1 | 2010-10-18 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 40 mg | 022272 | 1 | 2010-10-04 |
US Patents and Regulatory Information for OXYCONTIN
OXYCONTIN is protected by twenty-one US patents.
Patents protecting OXYCONTIN
Abuse-proofed dosage form
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Abuse-proofed dosage form
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Process for preparing oxycodone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Crush resistant delayed-release dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Abuse-proofed dosage form
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Oxycodone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Abuse-proofed dosage form
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Tamper resistant dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-004 | Apr 5, 2010 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-002 | Apr 5, 2010 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-002 | Apr 5, 2010 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXYCONTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-002 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OXYCONTIN
See the table below for patents covering OXYCONTIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 2311459 | ⤷ Sign Up | |
Croatia | P20110147 | ⤷ Sign Up | |
Serbia | 51591 | FARMACEUTSKI DOZNI OBLICI REZISTENTNI NA ZLOUPOTREBU KOJI SADRŽE OPIOIDNI ANALGETIK (TAMPER RESISTANT ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING AN OPIOID ANALGESIC) | ⤷ Sign Up |
Finland | 113152 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OXYCONTIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |